The R2-ISS in a Multicenter Cohort of Chinese Patients With Newly Diagnosed Multiple Myeloma
Hemasphere
.
2023 Mar 24;7(4):e857.
doi: 10.1097/HS9.0000000000000857.
eCollection 2023 Apr.
Authors
Peiyu Yang
1
2
,
Fan Zhou
3
,
Yujun Dong
4
,
Guangxun Gao
5
,
Hua Xue
6
,
Xinyue Liang
1
,
Shanshan Yu
1
,
Weiling Xu
7
,
Yanping Ma
8
,
Xiaoqi Qin
8
,
Mengyao Li
1
8
,
Yun Dai
2
,
Fengyan Jin
1
Affiliations
1
Department of Hematology, First Hospital of Jilin University, Changchun, Jilin, China.
2
Laboratory of Cancer Precision Medicine, First Hospital of Jilin University, Changchun, Jilin, China.
3
Department of Hematology and Oncology, Shanghai Jing'an District Zhabei Central Hospital, Shanghai, China.
4
Department of Hematology, Peking University First Hospital, Beijing, China.
5
Department of Hematology, Xijing Hospital, Air Force Medical University, Xi'an, Shanxi, China.
6
Department of Hematology, Affiliated Hospital of Hebei University, Baoding, Hebei, China.
7
Department of Radiology, First Hospital of Jilin University, Changchun, Jilin, China.
8
Department Hematology, Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
PMID:
36999007
PMCID:
PMC10043562
DOI:
10.1097/HS9.0000000000000857
No abstract available